Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

被引：9
|
作者：
Grommes, Christian
Gavrilovic, Igor T.
Kaley, Thomas Joseph
Nolan, Craig
Omuro, Antonio Marcilio Padula
Wolfe, Julia
Pentsova, Elena
Hatzoglou, Vaios
Mellinghoff, Ingo K.
DeAngelis, Lisa Marie
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7515
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Single-Agent Ibrutinib Demonstrates Safety and Durability of Response at 2 Years Follow-up in Patients with Relapsed or Refractory Mantle Cell Lymphoma: Updated Results of an International, Multicenter, Open-Label Phase 2 Study
    Wang, Michael
    Rule, Simon
    Martin, Peter
    Goy, Andre
    Auer, Rebecca
    Kahl, Brad S.
    Jurczak, Wojciech
    Advani, Ranjana
    Romaguera, Jorge E.
    Williams, Michael E.
    Barrientos, Jacqueline C.
    Chmielowska, Ewa
    Radford, John
    Stilgenbauer, Stephan
    Dreylingls, Martin
    Jedrzejczak, Wieslaw Wiktor
    Johnson, Peter W.
    Spurgeon, Stephen E.
    Zhang, Liang
    Baher, Linda
    Cheng, Mei
    Beaupre, Darrin M.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [42] Elderly patients with primary CNS lymphoma: Results from the G-PCNSL-SG-1 trial
    Roth, Patrick
    Martus, Peter
    Kiewe, Philipp M.
    Moehle, Robert
    Klasen, Hermann A.
    Rauch, Michael
    Roeth, Alexander
    Kaun, Stephan
    Thiel, Eckhard
    Korfel, Agnieszka
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma
    Grommes, Christian
    Nandakumar, Subhiksha
    Schaff, Lauren R.
    Gavrilovic, Igor
    Kaley, Thomas J.
    Nolan, Craig P.
    Stone, Jacqueline
    Thomas, Alissa A.
    Tang, Sarah S.
    Wolfe, Julia
    Bozza, Alexis
    Wongchai, Venissala
    Hyde, Alisson
    Barrett, Emma
    Lynch, Elizabeth A.
    Madzsar, Juli T.
    Lin, Andrew
    Piotrowski, Anna F.
    Pentsova, Elena
    Francis, Jasmine H.
    Hatzoglou, Vaios
    Schultz, Nikolaus
    Reiner, Anne S.
    Panageas, Katherine S.
    Deangelis, Lisa M.
    Mellinghoff, Ingo K.
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 4005 - 4015
  • [44] Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Grommes, Christian
    Tang, Sarah S.
    Wolfe, Julia
    Kaley, Thomas J.
    Daras, Mariza
    Pentsova, Elena I.
    Piotrowski, Anna F.
    Stone, Jacqueline
    Lin, Andrew
    Nolan, Craig P.
    Manne, Malbora
    Codega, Paolo
    Campos, Carl
    Viale, Agnes
    Thomas, Alissa A.
    Berger, Michael F.
    Hatzoglou, Vaios
    Reiner, Anne S.
    Panageas, Katherine S.
    DeAngelis, Lisa M.
    Mellinghoff, Ingo K.
    BLOOD, 2019, 133 (05) : 436 - 445
  • [45] Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
    Michael Wang
    Simon Rule
    Pier Luigi Zinzani
    Andre Goy
    Olivier Casasnovas
    Stephen D. Smith
    Gandhi Damaj
    Jeanette K. Doorduijn
    Thierry Lamy
    Franck Morschhauser
    Carlos Panizo
    Bijal Shah
    Andrew Davies
    Richard Eek
    Jehan Dupuis
    Eric Jacobsen
    Arnon P. Kater
    Steven Le Gouill
    Lucie Oberic
    Tadeusz Robak
    Preetesh Jain
    Melanie M. Frigault
    Raquel Izumi
    Dorothy Nguyen
    Priti Patel
    Ming Yin
    Monika Długosz-Danecka
    Leukemia, 2019, 33 : 2762 - 2766
  • [46] Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Olivier
    Smith, Stephen D.
    Damaj, Gandhi
    Doorduijn, Jeanette K.
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Le Gouill, Steven
    Oberic, Lucie
    Robak, Tadeusz
    Jain, Preetesh
    Frigault, Melanie M.
    Izumi, Raquel
    Dorothy Nguyen
    Patel, Priti
    Yin, Ming
    Dlugosz-Danecka, Monika
    LEUKEMIA, 2019, 33 (11) : 2762 - 2766
  • [47] Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.
    Grommes, Christian
    Stone, Jacqueline
    Nolan, Craig
    Tsyvkin, Elina
    Wolfe, Julia
    Mellinghoff, Ingo K.
    DeAngelis, Lisa Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Single-Agent Ibrutinib Demonstrates Efficacy and Safety in Patients with Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Phase 2 Study
    Noy, Ariela
    de Vos, Sven
    Thieblemont, Catherine
    Martin, Peter
    Flowers, Christopher
    Morschhauser, Franck
    Collins, Graham P.
    Ma, Shuo
    Coleman, Morton
    Peles, Shachar
    Smith, Stephen
    Smith, Alina
    Munneke, Brian
    Dimery, Isaiah
    Beaupre, Darrin
    Chen, Robert W.
    BLOOD, 2016, 128 (22)
  • [49] Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids
    Kurtuncu, Murat
    Tuzun, Erdem
    Durmus, Hacer
    Mutlu, Melike
    Akman-Demir, Gulsen
    Eraksoy, Mefkure
    LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1552 - 1553
  • [50] A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide
    Wong, S. F.
    Gan, H. K.
    Cher, L.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (11) : 1501 - 1505
12345